SEC Form 3 · accession 0001209191-19-008229
Harpoon Therapeutics, Inc. · HARP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Baeuerle
Director
Period of report
Feb 7, 2019
Accepted (ET)
Feb 7, 2019 · 6:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001708493
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 349,515 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F2 | $2.12 | holding | — | — | — | — | Dec 19, 2028 | Common Stock | 20,335 | — | D |
Explanation of responses
- F1Shares indirectly held by APAK Solutions GmbH, of which the Reporting Person has sole voting and investment power over these shares.
- F2The stock option vests in three annual installments starting on December 19, 2019, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.